Prescription drug · NDA
Brevibloc (esmolol hydrochloride) NDC 10019-666
Esmolol hydrochloride 20 mg/mL · Injection · Intravenous · Baxter Healthcare Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 10019-666-10 | 10019066610 | 10 BAG in 1 CARTON (10019-666-10) / 100 mL in 1 BAGMarketed from Nov 1, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brevibloc
- Generic name (nonproprietary)
- esmolol hydrochloride
- Active ingredients
- Esmolol hydrochloride — 20 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Baxter Healthcare Company
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019386
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 10019-666_5880588d-ee12-4ca7-ac0b-489d65babf3aSPL ID 5880588d-ee12-4ca7-ac0b-489d65babf3aSPL set ID 9c593cdb-cdfe-4492-8862-9b05116aa25eRxCUI 979432, 979434, 1736541, 1736543UNII V05260LC8D
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N410019066610followed by a unit qualifier and the quantityPackage 10019-0666-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under NDA 019386
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Henry Schein, Inc | 0404-9825 |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1427 |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Medical Purchasing Solutions, LLC | 71872-7136 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-668 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-670 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-672 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-055 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-075 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-115 |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Corporation | 10019-120 |